cro.directory
← Compare landing

Aldeyra Therapeutics vs Lotus Clinical Research

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/aldeyra/lotuscr

CategoryAldeyra TherapeuticsLotus Clinical Research
Listed sitecrocro
SummaryBiopharmaceutical company developing immunomodulatory therapies for immune-mediated ocular and systemic diseases, with late-stage clinical candidates targeting dry eye disease, allergic conjunctivitis, and retinal conditions.Specialized CRO supporting clinical development in neuroscience and metabolic disease across all phases, with direct access to 20 wholly-owned US research sites and 400+ beds.
Services
  • Phase III Clinical Trials
  • Phase II Clinical Trials
  • Clinical Operations
  • US FDA Regulatory Strategy
  • Immunology & Inflammation Services
  • Clinical Operations
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Data Management & eClinical
  • Biostatistics & Statistical Programming
  • Medical Writing
  • US FDA Regulatory Strategy
  • Regulatory Affairs
  • Clinical Trial Services
  • CNS Specialty Services
  • Cardiovascular & Metabolic Specialty Services
  • Immunology & Inflammation Services
  • Clinical Imaging Core Lab
Modalities
  • Small Molecule
Data not yet provided.
Indications
  • Immunology
  • Rare Disease
  • Ophthalmology
  • Oncology
  • Neurology
  • Psychiatry
  • Metabolic
LocationsData not yet provided.
  • Headquarters, Edison, NJ, United States
  • Headquarters, United States
  • Research Sites Network, United States, US
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.